SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-161192
Filing Date
2021-05-14
Accepted
2021-05-14 06:39:05
Documents
14
Period of Report
2021-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d102863d8k.htm   iXBRL 8-K 23963
2 EX-99.1 d102863dex991.htm EX-99.1 64141
6 GRAPHIC g102863dsp1.jpg GRAPHIC 7095
  Complete submission text file 0001193125-21-161192.txt   237428

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgem-20210514.xsd EX-101.SCH 3093
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20210514_lab.xml EX-101.LAB 19656
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20210514_pre.xml EX-101.PRE 12330
7 EXTRACTED XBRL INSTANCE DOCUMENT d102863d8k_htm.xml XML 3611
Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 21921869
SIC: 2836 Biological Products, (No Diagnostic Substances)